Related Experiment Video

Updated: May 24, 2026

Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay
11:14

Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay

Published on: November 10, 2013

Cytotoxicity of a Ti(IV) compound is independent of serum proteins

Arthur D Tinoco1, Horatio R Thomas, Christopher D Incarvito

  • 1Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA 02138, USA. atinoco@fas.harvard.edu

Proceedings of the National Academy of Sciences of the United States of America
|March 14, 2012
PubMed

Insights

Titanium(IV) compounds show anticancer promise. Researchers found that the ligand N,N'-di(o-hydroxybenzyl)ethylenediamine-N,N'-diacetic acid (HBED) is crucial for titanium(IV) compound cytotoxicity against lung cancer cells.

Area of Science:

  • Inorganic Chemistry
  • Medicinal Chemistry
  • Cancer Biology

Background:

  • Titanium(IV) compounds are promising anticancer agents but lack clinical success due to poorly understood mechanisms.
  • Developing new titanium(IV) anticancer drugs is hindered by limited knowledge of their bioactivity drivers.

Purpose of the Study:

  • To identify key factors governing titanium(IV) compound bioactivity.
  • To evaluate the cytotoxicity of various titanium(IV) compounds with different ligands.
  • To investigate the role of serum protein interactions in titanium(IV) compound activity.

Main Methods:

  • Cytotoxicity assays using A549 lung cancer cells.
  • Speciation studies to analyze compound forms in solution.
  • Mass spectrometry for bioavailability measurements.
  • Characterization of ligand properties.

Main Results:

  • The titanium(IV) compound with N,N"-di(o-hydroxybenzyl)ethylenediamine-N,Nest-diacetic acid (HBED) ligand demonstrated significant cytotoxicity against A549 lung cancer cells.
  • Compounds with citrate and naphthalene-2,3-diolate ligands showed no significant cytotoxicity.
  • Interactions with serum proteins were found not to influence the activity of the [TiO(HBED)]- compound.
  • Specific ligand properties essential for bioactivity were identified.

Conclusions:

  • The ligand structure is critical for the bioactivity of titanium(IV) anticancer compounds.
  • The [TiO(HBED)]- compound is a unique candidate for anticancer drug development.
  • These findings provide a foundation for designing next-generation titanium(IV) anticancer agents.

More Related Videos

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia10:49

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Published on: September 18, 2013

Isolation and Expansion of Cytotoxic Cytokine-induced Killer T Cells for Cancer Treatment11:11

Isolation and Expansion of Cytotoxic Cytokine-induced Killer T Cells for Cancer Treatment

Published on: January 24, 2020

Related Concept Videos

Drug toxicity: Idiosyncratic Reactions01:16

Drug toxicity: Idiosyncratic Reactions

Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
EDTA: Auxiliary Complexing Reagents01:26

EDTA: Auxiliary Complexing Reagents

EDTA titrations are usually carried out in highly basic conditions, where the fully deprotonated form of EDTA, Y4−, actively complexes with the free metal ions in the solution. Several metal ions precipitate as hydrous oxide (hydroxides, oxides, or oxyhydroxides) under these conditions, lowering the concentration of free metal ions in the solution. For this reason, auxiliary complexing agents or ligands such as ammonia, tartrate, citrate, or triethanolamine are used in EDTA titrations to...
Therapeutic Index01:13

Therapeutic Index

The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...
Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
Toxicokinetics: Overview01:21

Toxicokinetics: Overview

Studies that assess how a drug is absorbed, distributed, metabolized, and excreted (ADME) at toxic doses are termed toxicokinetics. Understanding toxicokinetics helps predict adverse drug reactions (ADRs) and manage toxicity in humans.Toxicokinetics differs from pharmacokinetics mainly in the dose levels studied, with toxicokinetics focusing on higher toxic doses. The kinetics at these levels can be non-linear due to altered physiological processes. Toxicodynamics examines the relationship...